Skip to main content
SpringerLink
Log in

Tobacco Use in Patients with HIV

  • Chapter
  • First Online:
Cardiovascular Care in Patients With HIV

Abstract

Tobacco use, mainly in the form of cigarette smoking, is hyper-prevalent among persons living with HIV (PLWH). In the early days of the epidemic, smoking received little attention because most patients succumbed to their disease before tobacco-related morbidities could manifest themselves. In the HAART era, patients are surviving longer with their HIV but are suffering from tobacco-related morbidity and mortality at alarming rates. Smoking is associated with a wide range of HIV-related and HIV-unrelated disease processes. Today’s HIV-infected community as a whole loses more years to tobacco use than to the virus itself.

This chapter reviews the history, pathophysiology, epidemiology, behavioral bases, and treatment of tobacco use in PLWH.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. United States Public Health Service. Smoking and Health: Report of the advisory committee to the Surgeon General of the Public Health Service. Public Health Service publication 1103. January 1964.

    Google Scholar 

  2. United States Public Health Service. The Health Consequences of Smoking: 1968 Supplement to the 1967 Public Health Service Review. Public Health Service publication 1696. 1968.

    Google Scholar 

  3. Garrett BE, Dube SR, Trosclair A, Caraballo RS, Pechacek TF, Centers for Disease C, et al. Cigarette smoking – United States, 1965-2008. MMWR Suppl. 2011;60(1):109–13.

    PubMed  Google Scholar 

  4. Hu SS, Neff L, Agaku IT, Cox S, Day HR, Holder-Hayes E, et al. Tobacco Product Use Among Adults – United States, 2013-2014. MMWR Morb Mortal Wkly Rep. 2016;65(27):685–91.

    Article  PubMed  Google Scholar 

  5. Mdodo R, Frazier EL, Dube SR, Mattson CL, Sutton MY, Brooks JT, et al. Cigarette smoking prevalence among adults with HIV compared with the general adult population in the United States: cross-sectional surveys. Ann Intern Med. 2015;162(5):335–44.

    Article  PubMed  Google Scholar 

  6. Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56(5):727–34.

    Article  PubMed  Google Scholar 

  7. Marcus JL, Chao CR, Leyden WA, Xu L, Quesenberry CP Jr, Klein DB, et al. Narrowing the Gap in Life Expectancy Between HIV-Infected and HIV-Uninfected Individuals With Access to Care. J Acquir Immune Defic Syndr. 2016;73(1):39–46.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Schechter MT, Boyko WJ, Jeffries E, Willoughby B, Nitz R, Constance P, et al. The Vancouver Lymphadenopathy-AIDS Study: 4. Effects of exposure factors, cofactors and HTLV-III seropositivity on number of helper T cells. Can Med Assoc J. 1985;133(4):286–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Newell GR, Mansell PW, Wilson MB, Lynch HK, Spitz MR, Hersh EM. Risk factor analysis among men referred for possible acquired immune deficiency syndrome. Prev Med. 1985;14(1):81–91.

    Article  CAS  PubMed  Google Scholar 

  10. Burns DN, Kramer A, Yellin F, Fuchs D, Wachter H, DiGioia RA, et al. Cigarette smoking: a modifier of human immunodeficiency virus type 1 infection? J Acquir Immune Defic Syndr. 1991;4(1):76–83.

    Article  CAS  PubMed  Google Scholar 

  11. Royce RA, Winkelstein W Jr. HIV infection, cigarette smoking and CD4+ T-lymphocyte counts: preliminary results from the San Francisco Men's Health Study. AIDS. 1990;4(4):327–33.

    Article  CAS  PubMed  Google Scholar 

  12. Fischl MA, Richman DD, Grieco MH, Gottlieb MS, Volberding PA, Laskin OL, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med. 1987;317(4):185–91.

    Article  CAS  PubMed  Google Scholar 

  13. Swango PA, Kleinman DV, Konzelman JL. HIV and periodontal health. A study of military personnel with HIV. J Am Dent Assoc. 1991;122(7):49–54.

    Article  CAS  PubMed  Google Scholar 

  14. Syrjanen S, Valle SL, Antonen J, Suni J, Saxinger C, Krohn K, et al. Oral candidal infection as a sign of HIV infection in homosexual men. Oral Surg Oral Med Oral Pathol. 1988;65(1):36–40.

    Article  CAS  PubMed  Google Scholar 

  15. Hirschtick RE, Glassroth J, Jordan MC, Wilcosky TC, Wallace JM, Kvale PA, et al. Bacterial pneumonia in persons infected with the human immunodeficiency virus. Pulmonary Complications of HIV Infection Study Group. N Engl J Med. 1995;333(13):845–51.

    Article  CAS  PubMed  Google Scholar 

  16. Mitchell DM, Fleming J, Pinching AJ, Harris JR, Moss FM, Veale D, et al. Pulmonary function in human immunodeficiency virus infection. A prospective 18-month study of serial lung function in 474 patients. Am Rev Respir Dis. 1992;146(3):745–51.

    Article  CAS  PubMed  Google Scholar 

  17. Galai N, Park LP, Wesch J, Visscher B, Riddler S, Margolick JB. Effect of smoking on the clinical progression of HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(5):451–8.

    Article  CAS  PubMed  Google Scholar 

  18. Chaisson RE. Smoking cessation in patients with HIV. JAMA. 1994;272(7):564.

    Article  CAS  PubMed  Google Scholar 

  19. Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now. Clin Infect Dis. 2000;31(3):808–12.

    Article  CAS  PubMed  Google Scholar 

  20. Fiore MC, Jaen CR, Baker TB, et al. United States Public Health Service. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD.

    Google Scholar 

  21. Burns DN, Hillman D, Neaton JD, Sherer R, Mitchell T, Capps L, et al. Cigarette smoking, bacterial pneumonia, and other clinical outcomes in HIV-1 infection. Terry Beirn Community Programs for Clinical Research on AIDS. J Acquir Immune Defic Syndr Hum Retrovirol. 1996;13(4):374–83.

    Article  CAS  PubMed  Google Scholar 

  22. Moorman AC, Holmberg SD, Marlowe SI, Von Bargen JC, Yangco BG, Palella FJ, et al. Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS). Ann Epidemiol. 1999;9(6):349–57.

    Article  CAS  PubMed  Google Scholar 

  23. Miguez-Burbano MJ, Burbano X, Ashkin D, Pitchenik A, Allan R, Pineda L, et al. Impact of tobacco use on the development of opportunistic respiratory infections in HIV seropositive patients on antiretroviral therapy. Addict Biol. 2003;8(1):39–43.

    Article  PubMed  Google Scholar 

  24. Marcus JL, Baxter R, Leyden WA, Muthulingam D, Yee A, Horberg MA, et al. Invasive Pneumococcal Disease Among HIV-Infected and HIV-Uninfected Adults in a Large Integrated Healthcare System. AIDS Patient Care STDs. 2016;30(10):463–70.

    Article  PubMed  Google Scholar 

  25. Palacio H, Hilton JF, Canchola AJ, Greenspan D. Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;14(4):338–42.

    Article  CAS  PubMed  Google Scholar 

  26. Shuter J, Bernstein SL. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008;10(4):731–6.

    Article  CAS  PubMed  Google Scholar 

  27. Feldman JG, Minkoff H, Schneider MF, Gange SJ, Cohen M, Watts DH, et al. Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health. 2006;96(6):1060–5.

    Article  PubMed  PubMed Central  Google Scholar 

  28. Rossouw TM, Anderson R, Feldman C. Impact of HIV infection and smoking on lung immunity and related disorders. Eur Respir J. 2015;46(6):1781–95.

    Article  CAS  PubMed  Google Scholar 

  29. Alpagot T, Duzgunes N, Wolff LF, Lee A. Risk factors for periodontitis in HIV patients. J Periodontal Res. 2004;39(3):149–57.

    Article  PubMed  Google Scholar 

  30. Haigentz M Jr. Aerodigestive cancers in HIV infection. Curr Opin Oncol. 2005;17(5):474–8.

    Article  PubMed  Google Scholar 

  31. Chin KM, Sidhu JS, Janssen RS, Weber JT. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients. Obstet Gynecol. 1998;92(1):83–7.

    Article  CAS  PubMed  Google Scholar 

  32. Klein RS, Ho GY, Vermund SH, Fleming I, Burk RD. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis. 1994;170(6):1404–9.

    Article  CAS  PubMed  Google Scholar 

  33. Wieland U, Hellmich M, Wetendorf J, Potthoff A, Hofler D, Swoboda J, et al. Smoking and anal high-risk human papillomavirus DNA loads in HIV-positive men who have sex with men. Int J Med Microbiol. 2015;305(7):689–96.

    Article  PubMed  Google Scholar 

  34. Mondy K, Yarasheski K, Powderly WG, Whyte M, Claxton S, DeMarco D, et al. Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis. 2003;36(4):482–90.

    Article  PubMed  Google Scholar 

  35. Howard AA, Floris-Moore M, Arnsten JH, Santoro N, Fleischer N, Lo Y, et al. Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis. 2005;40(10):1492–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Ryom L, Mocroft A, Kirk O, Ross M, Reiss P, Fux CA, et al. Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons. AIDS. 2014;28(2):187–99.

    Article  PubMed  Google Scholar 

  37. Zyambo CM, Willig JH, Cropsey KL, Carson AP, Wilson C, Tamhane AR, et al. Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care. J AIDS Clin Res. 2015;6(7):480.

    Google Scholar 

  38. Allavena C, Guimard T, Billaud E, De la Tullaye S, Reliquet V, Pineau S, et al. Prevalence and Risk Factors of Sleep Disturbance in a Large HIV-Infected Adult Population. AIDS Behav. 2016;20(2):339–44.

    Article  CAS  PubMed  Google Scholar 

  39. Crothers K, Griffith TA, McGinnis KA, Rodriguez-Barradas MC, Leaf DA, Weissman S, et al. The impact of cigarette smoking on mortality, quality of life, and comorbid illness among HIV-positive veterans. J Gen Intern Med. 2005;20(12):1142–5.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Lifson AR, Neuhaus J, Arribas JR, van den Berg-Wolf M, Labriola AM, Read TR, et al. Smoking-related health risks among persons with HIV in the Strategies for Management of Antiretroviral Therapy clinical trial. Am J Public Health. 2010;100(10):1896–903.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Friis-Moller N, Sabin CA, Weber R, d'Arminio Monforte A, El-Sadr WM, Reiss P, et al. Combination antiretroviral therapy and the risk of myocardial infarction. N Engl J Med. 2003;349(21):1993–2003.

    Article  PubMed  Google Scholar 

  42. Kelly SG, Plankey M, Post WS, Li X, Stall R, Jacobson LP, et al. Associations between Tobacco, Alcohol, and Drug Use with Coronary Artery Plaque among HIV-Infected and Uninfected Men in the Multicenter AIDS Cohort Study. PLoS One. 2016;11(1):e0147822.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  43. Freiberg MS, Chang CC, Kuller LH, Skanderson M, Lowy E, Kraemer KL, et al. HIV infection and the risk of acute myocardial infarction. JAMA Intern Med. 2013;173(8):614–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Paisible AL, Chang CC, So-Armah KA, Butt AA, Leaf DA, Budoff M, et al. HIV infection, cardiovascular disease risk factor profile, and risk for acute myocardial infarction. J Acquir Immune Defic Syndr. 2015;68(2):209–16.

    Article  PubMed  Google Scholar 

  45. D'Ascenzo F, Quadri G, Cerrato E, Calcagno A, Omede P, Grosso Marra W, et al. A meta-analysis investigating incidence and features of stroke in HIV-infected patients in the highly active antiretroviral therapy era. J Cardiovasc Med (Hagerstown). 2015;16(12):839–43.

    Article  Google Scholar 

  46. Mateen FJ, Post WS, Sacktor N, Abraham AG, Becker JT, Smith BR, et al. Long-term predictive value of the Framingham Risk Score for Stroke in HIV-positive vs HIV-negative men. Neurology. 2013;81(24):2094–102.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Knudsen A, Malmberg CA, Kjaer A, Lebech AM. Low prevalence of peripheral arterial disease in a cross-sectional study of Danish HIV-infected patients. Infect Dis (Lond). 2015;47(11):776–82.

    Article  Google Scholar 

  48. Sharma A, Holman S, Pitts R, Minkoff HL, Dehovitz JA, Lazar J. Peripheral arterial disease in HIV-infected and uninfected women. HIV Med. 2007;8(8):555–60.

    Article  CAS  PubMed  Google Scholar 

  49. Gill MJ, Costagliola D. Editorial commentary: Myocardial infarction in HIV-infected persons: time to focus on the silent elephant in the room? Clin Infect Dis. 2015;60(9):1424–5.

    PubMed  Google Scholar 

  50. d'Ettorre G, Ceccarelli G, Pavone P, Vittozzi P, De Girolamo G, Schietroma I, et al. What happens to cardiovascular system behind the undetectable level of HIV viremia? AIDS Res Ther. 2016;13:21.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  51. Stein JH, Hsue PY. Inflammation, immune activation, and CVD risk in individuals with HIV infection. JAMA. 2012;308(4):405–6.

    Article  CAS  PubMed  Google Scholar 

  52. Subramanian S, Tawakol A, Burdo TH, Abbara S, Wei J, Vijayakumar J, et al. Arterial inflammation in patients with HIV. JAMA. 2012;308(4):379–86.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, et al. Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity. J Antimicrob Chemother. 2015;70(6):1816–24.

    CAS  PubMed  Google Scholar 

  54. Kooij KW, Wit FW, Booiman T, van der Valk M, Schim van der Loeff MF, Kootstra NA, et al. Cigarette smoking and inflammation, monocyte activation and coagulation in HIV-infected individuals on antiretroviral therapy compared to uninfected individuals. J Infect Dis. 2016;214(12):1817–21.

    Google Scholar 

  55. Valiathan R, Miguez MJ, Patel B, Arheart KL, Asthana D. Tobacco smoking increases immune activation and impairs T-cell function in HIV infected patients on antiretrovirals: a cross-sectional pilot study. PLoS One. 2014;9(5):e97698.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  56. Benjamin JL, Hedin CR, Koutsoumpas A, Ng SC, McCarthy NE, Prescott NJ, et al. Smokers with active Crohn's disease have a clinically relevant dysbiosis of the gastrointestinal microbiota. Inflamm Bowel Dis. 2012;18(6):1092–100.

    Article  PubMed  Google Scholar 

  57. Lupia E, Bosco O, Goffi A, Poletto C, Locatelli S, Spatola T, et al. Thrombopoietin contributes to enhanced platelet activation in cigarette smokers. Atherosclerosis. 2010;210(1):314–9.

    Article  CAS  PubMed  Google Scholar 

  58. Gilbert JM, Fitch KV, Grinspoon SK. HIV-Related Cardiovascular Disease, Statins, and the REPRIEVE Trial. Top Antivir Med. 2015;23(4):146–9.

    PubMed  Google Scholar 

  59. Agaku IT, King BA, Husten CG, Bunnell R, Ambrose BK, Hu SS, Holder-Hayes E, Day HR. Tobacco product use among adults – United States, 2012-2013. Morbitity and Mortality Weeky Report. 2014;63(25):542–7.

    Google Scholar 

  60. Asma S, Mackay J, Song SY, Zhao L, Morton J, Palipudi KM, Bettcher D, Bhatti L, Caixeta R, Chandora R, Dias RC, da Costa e Silva VL, Fouad H, Hsia J, Husain MJ, McAfee T, Ramanandraibe N, Rarick J, Sinha D, Talley B, d’Espaignet ET, GATS Collaborative Group. The GATS Atlas. 2015. Atlanta, GA: CDC Foundation; 2015.

    Google Scholar 

  61. Park LS, Hernandez-Ramirez RU, Silverberg MJ, Crothers K, Dubrow R. Prevalence of non-HIV cancer risk factors in persons living with HIV/AIDS: a meta-analysis. AIDS. 2016;30(2):273–91.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Ledgerwood DM, Yskes R. Smoking Cessation for People Living With HIV/AIDS: A Literature Review and Synthesis. Nicotine Tob Res. 2016;18(12):2177–84.

    Google Scholar 

  63. APA. Diagnostic and statistical manual of mental disorders. 5th ed. (DSM-V). Washington, DC: American Psychiatric Association; 2013.

    Google Scholar 

  64. Pomerleau OF, Pomerleau CS, Mehringer AM, Snedecor SM, Ninowski R, Sen A. Nicotine dependence, depression, and gender: Characterizing phenotypes based on withdrawal discomfort, response to smoking, and ability to abstain. Nicotine Tob Res. 2005;7(1):91–102.

    Article  PubMed  Google Scholar 

  65. Sienkiewicz-Jarosz H, Zatorski P, Baranowska A, Ryglewicz D, Bienkowski P. Predictors of smoking abstinence after first-ever ischemic stroke: A 3-month follow-up. Stroke. 2009;40(7):2592–3.

    Article  PubMed  Google Scholar 

  66. Pacek LR, Harrell PT, Martins SS. Cigarette smoking and drug use among a nationally representative sample of HIV-positive individuals. Am J Addict. 2014;23:582–90.

    Article  PubMed  PubMed Central  Google Scholar 

  67. Benard A, Bonnet F, Tessier JF, Fossoux H, Dupon M, Mercie P, et al. Tobacco addiction and HIV infection: toward the implementation of cessation programs. ANRS CO3 Aquitaine Cohort. AIDS Patient Care STDs. 2007;21(7):458–68.

    Article  PubMed  Google Scholar 

  68. Shuter J, Bernstein SL, Moadel AB. Cigarette smoking behaviors and beliefs in persons living with HIV/AIDS. Am J Health Behav. 2012;36(1):75–85.

    Article  PubMed  PubMed Central  Google Scholar 

  69. Gritz ER, Vidrine DJ, Lazev AB, Amick BC 3rd, Arduino RC. Smoking behavior in a low-income multiethnic HIV/AIDS population. Nicotine Tob Res. 2004;6(1):71–7.

    Article  PubMed  Google Scholar 

  70. Tesoriero JM, Gieryic SM, Carrascal A, Lavigne HE. Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation. AIDS & Behavior. 2010;14(4):824–35.

    Article  Google Scholar 

  71. McQueen A, Shacham E, Summer W, Overton ET. Beliefs, experience, and interest in pharmacotherapy among smokers with HIV. Am J Health Behav. 2014;38(2):284–96.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Interest in quitting and lifetime quit attempts among smokers living with HIV infection. Drug Alcohol Depend. 2014;138:220–4.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Hughes JR, Helzer JE, Lindberg SA. Prevalence of DSM/ICD-defined nicotine dependence. Drug Alcohol Depend. 2006;85:91–102.

    Article  PubMed  Google Scholar 

  74. Tami-Maury I, Vidrine DJ, Fletcher FE, Danysh H, Arduino R, Gritz ER. Poly-tobacco use among HIV-positive smokers: implications for smoking cessation efforts. Nicotine Tob Res. 2013;15(12):2100–6.

    Article  PubMed  PubMed Central  Google Scholar 

  75. Zyambo CM, Willig JH, Cropsey KL, Carson AP, Wilson C, Tamhane AR, Westfall AO, Burkholder GA. Factors Associated With Smoking Status among HIV-Positive Patients in Routine Clinical Care. Journal of AIDS and Clinical Research. 2015;6:7.

    Article  Google Scholar 

  76. Stewart DW, Jones GN, Minor KS. Smoking, depression, and gender in low-income African Americans with HIV/AIDS. Behav Med. 2011;37(3):77–80.

    Article  PubMed  Google Scholar 

  77. Webb MS, Vanable PA, Carey MP, Blair DC. Cigarette smoking among HIV+ men and women: examining health, substance use, and psychosocial correlates across the smoking spectrum. J Behav Med. 2007;30(5):371–83.

    Article  PubMed  PubMed Central  Google Scholar 

  78. Shirley DK, Kesari RK, Glesby MJ. Factors associated with smoking in HIV-infected patients and potential barriers to cessation. AIDS Patient Care STDs. 2013;27(11):604–12.

    Article  PubMed  PubMed Central  Google Scholar 

  79. Akhtar-Khaleel WZ, Cook RL, Shoptaw S, Surkan P, Stall R, Beyth RJ, Teplin LA, Plankey M. Trends and predictors of cigarette smoking among HIV seropositive and seronegative men: The multicenter aids cohort study. AIDS Behav. 2016;20(3):622–32.

    Article  PubMed  PubMed Central  Google Scholar 

  80. Burkhalter JE, Springer CM, Chhabra R, Ostroff JS, Rapkin BD. Tobacco use and readiness to quit smoking in low-income HIV-infected persons. Nicotine Tob Res. 2005;7(4):511–22.

    Article  PubMed  Google Scholar 

  81. Pence BW, Miller WC, Whetten K, Eron JJ, Gaynes BN. Prevalence of DSM-IV-defined mood, anxiety, and substance use disorders in an HIV clinic in the southeastern United States. J Acquir Immune Defic Syndr. 2006;42:298–306.

    Article  PubMed  Google Scholar 

  82. Parhami I, Fong TW, Siani A, Carlotti C, Khanlou H. Documentation of Psychiatric Disorders and Related Factors in a Large Sample Population of HIV-Positive Patients in California. AIDS Behav. 2013;17(8):2792–801.

    Article  PubMed  PubMed Central  Google Scholar 

  83. Ciesla JA, Roberts JE. Meta-analysis of the relationship between HIV infection and risk for depressive disorders. Am J Psychiatr. 2001;158:725–30.

    Article  CAS  PubMed  Google Scholar 

  84. Stanton CA, Moadel AB, Kim RS, Weinberger AH, Shuter J. Loneliness in HIV-infected smokers. AIDS Care. 2015;27(2):268–72.

    Article  PubMed  Google Scholar 

  85. Smith PH, Mazure CM, McKee SA. Smoking and mental illness in the US population. Tob Control. 2014;23:e147–e53.

    Article  PubMed  PubMed Central  Google Scholar 

  86. Weinberger AH, Kashan RS, Shpigel DM, Esan H, Taha F, Lee CJ, Funk AP, Goodwin RD. Depression and cigarette smoking behavior: a critical review of population-based studies. Am J Drug Alcohol Abuse. 2016; [Epub ahead of print]; https://doi.org/10.3109/00952990.2016.1171327.

  87. Pacek LR, Latkin C, Crum RM, Stuart EA, Knowlton AR. Current cigarette smoking among HIV-positive current and former drug users: associations with individual and social characteristics. AIDS & Behavior. 2014;18(7):1368–77.

    Article  Google Scholar 

  88. Weinberger AH, Funk AP, Goodwin RD. A review of epidemiologic research on smoking behavior among persons with alcohol and illicit substance use disorders. Prev Med. 2016; https://doi.org/10.1016/j.ypmed.2016.05.011. [Epub ahead of print].

  89. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Betancourt RM, Stein M, Tashima K, Morrow K, Niaura R. HIV-positive smokers considering quitting: differences by race/ethnicity. Am J Health Behav. 2008;32(1):3–12.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Shuter J, Moadel AB, Kim RS, Weinberger AH, Stanton CA. Self-efficacy to quit in HIV-infected smokers. Nicotine Tob Res. 2014;16(11):1527–31.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Baker TB, Brandon TH, Chassin L. Motivational influences on cigarette smoking. Annu Rev Psychol. 2004;55:463–91.

    Article  PubMed  Google Scholar 

  92. Brandon TH, Baker TB. The Smoking Consequences Questionnaire: The subjective expected utility of smoking in college students. Psychol Assess. 1991;3:484–91.

    Article  Google Scholar 

  93. Peretti-Watel P, Garelik D, Baron G, Spire B, Ravaud P, Duval X, et al. Smoking motivations and quitting motivations among HIV-infected smokers. Antivir Ther. 2009;14(6):781–7.

    Article  PubMed  Google Scholar 

  94. Reynolds NR, Neidig JL, Wewers ME. Illness representation and smoking behavior: A focus group study of HIV-positive men. J Assoc Nurses AIDS Care. 2004;15(4):37–47.

    Article  PubMed  Google Scholar 

  95. Grover KW, Gonzalez A, Zvolensky MJ. HIV symptom distress and smoking outcome expectancies among HIV+ smokers: A pilot test. AIDS Patient Care STDs. 2013;27(1):17–21.

    Article  PubMed  Google Scholar 

  96. Mamary EM, Bahrs D, Martinez S. Cigarette smoking and the desire to quit among individuals living with HIV. AIDS Patient Care STDs. 2002;16(1):39–42.

    Article  PubMed  Google Scholar 

  97. Shapiro AE, Tshabangu N, Golub JE, Martinson NA. Intention to quit smoking among human immunodeficiency virus infected adults in Johannesburg, South Africa. Int J Tuberc Lung Dis. 2011;15(1):140–2.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. Shuter J, Salmo LN, Shuter AD, Nivasch EC, Fazzari M, Moadel AB. Provider beliefs and practices relating to tobacco use in patients living with HIV/AIDS: a national survey. AIDS Behav. 2012;16(2):288–94.

    Article  PubMed  PubMed Central  Google Scholar 

  99. Keith A, Dong Y, Shuter J, Himelhoch S. Behavioral Interventions for Tobacco Use in HIV-Infected Smokers: A Meta-Analysis. J Acquir Immune Defic Syndr. 2016;72(5):527–33.

    CAS  PubMed  Google Scholar 

  100. Pool ER, Dogar O, Lindsay RP, Weatherburn P, Siddiqi K. Interventions for tobacco use cessation in people living with HIV and AIDS. Cochrane Database Syst Rev. 2016;6:CD011120.

    Google Scholar 

  101. Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, et al. Motivation and patch treatment for HIV+ smokers: a randomized controlled trial. Addiction. 2009;104(11):1891–900.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Stanton CA, Papandonatos GD, Shuter J, Bicki A, Lloyd-Richardson EE, de Dios MA, et al. Outcomes of a Tailored Intervention for Cigarette Smoking Cessation Among Latinos Living With HIV/AIDS. Nicotine Tob Res. 2015;17(8):975–82.

    Article  PubMed  PubMed Central  Google Scholar 

  103. Pedrol-Clotet E, Deig-Comerma E, Ribell-Bachs M, Vidal-Castell I, Garcia-Rodriguez P, Soler A. Bupropion use for smoking cessation in HIV-infected patients receiving antiretroviral therapy. Enferm Infecc Microbiol Clin. 2006;24(8):509–11.

    Article  PubMed  Google Scholar 

  104. Cui Q, Robinson L, Elston D, Smaill F, Cohen J, Quan C, et al. Safety and tolerability of varenicline tartrate (Champix((R))/Chantix((R))) for smoking cessation in HIV-infected subjects: a pilot open-label study. AIDS Patient Care STDs. 2012;26(1):12–9.

    Article  PubMed  PubMed Central  Google Scholar 

  105. Ferketich AK, Diaz P, Browning KK, Lu B, Koletar SL, Reynolds NR, et al. Safety of varenicline among smokers enrolled in the lung HIV study. Nicotine Tob Res. 2013;15(1):247–54.

    Article  CAS  PubMed  Google Scholar 

  106. Tseng TY, Krebs P, Schoenthaler A, Wong S, Sherman S, Gonzalez M, et al. Combining Text Messaging and Telephone Counseling to Increase Varenicline Adherence and Smoking Abstinence Among Cigarette Smokers Living with HIV: A Randomized Controlled Study. AIDS Behav. 2017;21(7):1964–74.

    Google Scholar 

  107. Elzi L, Spoerl D, Voggensperger J, Nicca D, Simcock M, Bucher HC, et al. A smoking cessation programme in HIV-infected individuals: a pilot study. Antivir Ther. 2006;11(6):787–95.

    PubMed  Google Scholar 

  108. Vidrine DJ, Arduino RC, Lazev AB, Gritz ER. A randomized trial of a proactive cellular telephone intervention for smokers living with HIV/AIDS. AIDS. 2006;20(2):253–60.

    Article  PubMed  Google Scholar 

  109. Ingersoll KS, Cropsey KL, Heckman CJ. A test of motivational plus nicotine replacement interventions for HIV positive smokers. AIDS Behav. 2009;13(3):545–54.

    Article  PubMed  Google Scholar 

  110. Moadel AB, Bernstein SL, Mermelstein RJ, Arnsten JH, Dolce EH, Shuter J. A randomized controlled trial of a tailored group smoking cessation intervention for HIV-infected smokers. J Acquir Immune Defic Syndr. 2012;61(2):208–15.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Vidrine DJ, Marks RM, Arduino RC, Gritz ER. Efficacy of cell phone-delivered smoking cessation counseling for persons living with HIV/AIDS: 3-month outcomes. Nicotine Tob Res. 2012;14(1):106–10.

    Article  PubMed  Google Scholar 

  112. Gritz ER, Danysh HE, Fletcher FE, Tami-Maury I, Fingeret MC, King RM, et al. Long-term outcomes of a cell phone-delivered intervention for smokers living with HIV/AIDS. Clin Infect Dis. 2013;57(4):608–15.

    Article  PubMed  PubMed Central  Google Scholar 

  113. Humfleet GL, Hall SM, Delucchi KL, Dilley JW. A randomized clinical trial of smoking cessation treatments provided in HIV clinical care settings. Nicotine Tob Res. 2013;15(8):1436–45.

    Article  PubMed  PubMed Central  Google Scholar 

  114. Shuter J, Morales DA, Considine-Dunn SE, An LC, Stanton CA. Feasibility and preliminary efficacy of a web-based smoking cessation intervention for HIV-infected smokers: a randomized controlled trial. J Acquir Immune Defic Syndr. 2014;67(1):59–66.

    Article  PubMed  PubMed Central  Google Scholar 

  115. Manuel JK, Lum PJ, Hengl NS, Sorensen JL. Smoking cessation interventions with female smokers living with HIV/AIDS: a randomized pilot study of motivational interviewing. AIDS Care. 2013;25(7):820–7.

    Article  PubMed  Google Scholar 

  116. Shelley D, Tseng TY, Gonzalez M, Krebs P, Wong S, Furberg R, et al. Correlates of Adherence to Varenicline Among HIV+ Smokers. Nicotine Tob Res. 2015;17(8):968–74.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  117. Wewers ME, Neidig JL, Kihm KE. The feasibility of a nurse-managed, peer-led tobacco cessation intervention among HIV-positive smokers. J Assoc Nurses AIDS Care. 2000;11(6):37–44.

    Article  CAS  PubMed  Google Scholar 

  118. Cropsey KL, Hendricks PS, Jardin B, Clark CB, Katiyar N, Willig J, et al. A pilot study of screening, brief intervention, and referral for treatment (SBIRT) in non-treatment seeking smokers with HIV. Addict Behav. 2013;38(10):2541–6.

    Article  PubMed  PubMed Central  Google Scholar 

  119. Vidrine DJ, Kypriotakis G, Li L, Arduino RC, Fletcher FE, Tami-Maury I, et al. Mediators of a smoking cessation intervention for persons living with HIV/AIDS. Drug Alcohol Depend. 2015;147:76–80.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Montefiore Medical Center and the Albert Einstein College of Medicine, Bronx, NY, USA

    Jonathan Shuter

  2. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA

    Jonathan Shuter & Andrea H. Weinberger

  3. Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA

    Andrea H. Weinberger

Authors
  1. Jonathan Shuter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Andrea H. Weinberger
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jonathan Shuter .

Editor information

Editors and Affiliations

  1. Bassett Research Institute, Bassett Medical Center, Cooperstown, NY, USA

    Merle Myerson

  2. Division of Infectious Diseases, Weill Cornell Medical College, New York, NY, USA

    Marshall J. Glesby

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Shuter, J., Weinberger, A.H. (2019). Tobacco Use in Patients with HIV. In: Myerson, M., Glesby, M. (eds) Cardiovascular Care in Patients With HIV. Springer, Cham. https://doi.org/10.1007/978-3-030-10451-1_7

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-10451-1_7

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-10450-4

  • Online ISBN: 978-3-030-10451-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation